Summary
This retrospective study evaluates the types and incidences of sexual disturbances and fertility distress in patients cured from testicular cancer and examines whether there is an effect resulting from different treatment modalities. A self-reported questionnaire was sent to 124 randomly selected patients who were treated at Hanover University Medical School between 1970 and 1993. Ninety-eight patients were included in the study, representing a response rate of 78%. All patients had been in complete remission (CR) for at least 24 months. The median age at diagnosis was 28 years (range 17–44). The median follow-up at the time of study was 12.0 years (range 2.8–25.6). Twenty patients (20%) had been treated for seminomatous and 78 patients (80%) for non-seminomatous germ cell tumours. Treatment included surveillance (7%), primary retroperitoneal lymph node dissection (RPLND) (13%), chemotherapy (CT) (33%), CT + secondary resection of residual retroperitoneal tumour mass (SRRTM) (43%) and infradiaphragmatic radiotherapy (4%). Patients receiving two treatment modalities (CT+SRRTM) reported more frequent an unfulfilled wish for children. Inability of ejaculation was clearly associated with RPLND and SRRTM. Subjective aspects of sexuality, like loss of sexual drive and reduced erectile potential, occurred only in a minority of patients after treatment. No abnormalities were observed concerning the course of pregnancies of partners. In conclusion, sexual dysfunction and infertility are common long-lasting sequelae in testicular cancer survivors affecting approximately 20% of patients. The relative risk for infertility appeared to be elevated for patients treated with the combination of CT+SRRTM. Twenty-one of 40 patients were able to fulfil their wish for children, and no congenital abnormalities were observed in these children.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aass, N., Fossa, S. D., Theodorson, L. & Norman, N. (1991). Prediction of long-term gonadal toxicity after standard treatment for testicular cancer. Eur J Cancer 27: 1087–1091.
Aass, N., Grunfeld, B., Kaalhus, O. & Fossa, S. D. (1993). Pre- and posttreatment sexual life in testicular cancer patients: a descriptive investigation. Br J Cancer 67: 1560–1567.
Arai, Y., Kawakita, M., Okada, Y. & Yoshida, O. (1997). Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 15: 1444–1448.
Berthelsen, J. G. & Skakkebaek, N. E. (1984). Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer. Fertil Steril 41: 281–286.
Bloom, J. R., Fobair, P., Gritz, E., Wellisch, D., Spiegel, D., Varghese, A. & Hoppe, R. (1993). Psychosocial outcomes of cancer: a comparative analysis of Hodgkin’s disease and testicular cancer. J Clin Oncol 11: 979–988.
Bokemeyer, C. (1998). Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors. Oncology 55: 177–188.
Bokemeyer, C., Kohrmann, O., Tischler, J., Weissbach, L., Rath, U., Haupt, A., Schöffski, P., Harstrick, A. & Schmoll, H. J. (1996). A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with ‘good-risk’ metastatic non-seminomatous germ cell tumors. Ann Oncol 7: 1015–1021.
Brenner, J., Vugrin, D. & Whitmore, W. (1985). Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumours of tests. Am J Clin Oncol 8: 178–182.
Bruckert, E. (1991). How frequent in unintentional childlessness in Germany?. Andrologica 23: 245–250.
Buena, F., Swerdloff, R. S., Steiner, B. S., Lutchmansingh, P., Peterson, M. A., Randian, M. R., Galmarini, M. & Bhasin, S. (1993). Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 59: 1118–1123.
Burns, L. H. (1987). Infertility as boundary ambiguity: one theoretical perspective. Fam Process 26: 359–372.
Byrne, J. & Mulvihill, J. J. (1991). Long-term survivors of childhood and adolescent cancer: their fertility and the health of their offsprings. In Complications of Cancer Management, Plowman PN, McElwain TJ, Meadows AT (eds), pp. 114–127. Butterworth Scientific: Guildford
Cassileth, B. R. & Steinfeld, A. D. (1987). Psychological preparation of the patient and family. Cancer 60: 547–552.
Cavalli, F., Monfadini, S. & Pizzocaro, G. (1980). Report on the international workshop on staging and treatment of testicular cancer. Eur J Cancer 16: 1367–1372.
Dodds, L., Marrett, L. D., Tomkins, D. J., Green, B. & Sherman, G. (1993). Case-control study of congenital anomalies in children of cancer patients. Br Med J 307: 164–168.
Drasga, R. E., Einhorn, L. H., Williams, S. D., Patel, D. N. & Stevens, E. E. (1983). Fertility after chemotherapy for testicular cancer. J Clin Oncol 3: 179–183.
Einhorn, L. H. (1990). Treatment of testicular cancer: a new and improved model. J Clin Oncol 8: 1777–1781.
El-Beheiry, A., Souka, A., El-Kamshoushi, A., Hussein, S. & El-Sabah, K. (1988). Hyperprolacteinia and impotence. Arch Androl 21: 211–214.
Fossa, S. D., Klepp, O. & Aakvaag, A. (1980). Serum hormone levels in patients with malignant testicular germ cell tumours without clinical and/or radiological signs of tumour. Br J Urol 52: 151–157.
Fossa, S. D., Ous, S., Abyholm, T., Norman, N. & Loeb, M. (1985). Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 57: 210–214.
Fossa, S. D., Abyholm, T., Norman, N. & Jetne, V. (1986). Post-treatment fertility in patients with testicular cancer. Br J Urol 58: 315–319.
Fossa, S. D., Aass, N. & Kaalhus, O. (1988). Testicular cancer in young Norwegians. J Surg Oncol 39: 43–63.
Goldstein, I., Feldman, M. I., Deckers, P. J., Babaian, R. K. & Krane, R. J. (1984). Radiation-associated impotence. A clinical study of its mechanism. JAMA 251: 903–910.
Gritz, E. R., Wellisch, D. K., Wang, H. J., Siau, J., Landsverk, J. A. & Cosgrove, M. D. (1989). Long-term effects of testicular cancer on sexual functioning in married couples. Cancer 64: 1560–1567.
Guazzerri, S., Lembo, A., Ferro, G., Artibani, W., Merlo, F., Zanchetta, R. & Pagano, F. (1985). Sperm antibodies and infertility in patients with testicular cancer. Urology 26: 139–142.
Harstrick, A., Schmoll, H. J., Kohne-Wompner, C. H., Bergmann, L., Lammers, U., Hohnloser, J., Dolken, G., Reichhardt, P., Siegert, W., Natt, F., Rath, V., Wilke, H. & Poliwoda, H. (1991). Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma. Ann Oncol 2: 197–202.
Hartmann, J. T., Candelaria, M., Kuczyk, M. A., Schmoll, H. J. & Bokemeyer, C. (1997a). Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours (NSGCT). Eur J Cancer 33: 843–847.
Hartmann, J. T., Schmoll, H. J., Kuczyk, M. A., Candelaria, M. & Bokemeyer, C. (1997b). Post-chemotherapy resections of residual tumor masses from metastastic non-seminomatous germ cell tumours. Ann Oncol 8: 531–538.
Hendry, W. F., Stedronska, J., Jones, C. R., Blackmore, C. A., Barrett, A. & Peckham, M. J. (1983). Semen analysis in testicular cancer and Hodgkin’s disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol 55: 769–773.
Jones, D. R., Norman, A. R., Horwich, A. & Hendry, W. F. (1993). Ejaculatory dysfunction after retroperitoneal lymphadenectomy. Eur Urol 23: 169–171.
Jonker-Pool, G., van Basten, J. P., Hoekstra, H. J., van Driel, M. F., Sleijfer, D. T., Koops, H. S. & van de Wiel, H. B. (1997). Sexual functioning after treatment for testicular cancer: comparison of treatment modalities. Cancer 80: 454–464.
Lampe, H., Horwich, A., Norman, A., Nicholls, J. & Dearnaley, D. P. (1997). Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15: 239–245.
Loehrer, P. J., Sr Lauer, R., Roth, B. J., Williams, S. D., Kalasinski, L. A. & Einhorn, L. H. (1988). Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109: 540–546.
Moynihan, C. (1987). Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv 6: 477–510.
Nijman, J. M., Schraffordt-Koops, H. S., Kremer, J. & Sleijfer, D. T. (1987). Gonadal function after surgery and chemotherapy in men with stage II and III non-seminomatous testicular tumors. J Clin Oncol 5: 651–656.
Petersen, P. M., Hansen, S. W., Giwercman, A., Rorth, M. & Skakkebaek, N. E. (1994). Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol 5: 355–358.
Rieker, P. P., Edbril, S. D. & Garnick, M. B. (1985). Curative testis cancer therapy: psychosocial sequelae. J Clin Oncol 3: 1117–1126.
Rieker, P. P., Fitzgerald, E. M., Kalish, L. A., Richie, J. P., Lederman, G. S., Edbril, S. D. & Garnick, M. B. (1989). Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer 64: 2399–2407.
Rieker, P. P., Fitzgerald, E. M. & Kalish, L. A. (1990). Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol 8: 347–355.
Sankila, R., Olsen, J. H., Anderson, H., Garwicz, S., Glattre, E., Hertz, H., Langmark, F., Lanning, M., Moller, T. & Tulinius, H. (1998). Risk of cancer among offspring of childhood-cancer survivors. N Engl J Med 338: 1339–1344.
Schmoll, H. J., Harstrick, A., Bokemeyer, C., Dieckmann, K. P., Clemm, C., Berdel, W. E., Souchon, R., Schöber, C., Wilke, H. & Poliwoda, H. (1993). Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer 72: 237–243.
Schover, L. R. (1987). Sexuality and fertility in urologic cancer patients. Cancer 60: 553–558.
Schover, L. R. & von Eschenbach, A. C. (1985). Sexual and marital relationships after treatment for non-seminomatous testicular cancer. Urology 25: 251–255.
Schover, L. R., Gonzales, M. & von Eschenbach, A. C. (1986). Sexual and marital relationships after radiotherapy for seminoma. Urology 27: 117–123.
Senturia, Y. D. & Peckham, C. S. (1990). Children fathered by men treated with chemotherapy for testicular cancer. Eur J Cancer 4: 429–432.
Sleijfer, S., van der Mark, T. W., Schraffordt-Koops, H. & Mulder, N. H. (1995). Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect. Br J Cancer 71: 120–123.
Stoter, G., Koopman, A., Vendrik, C. P., Struyvenberg, A., Sleyfer, D. T., Willemse, P. H., Schraffordt Koops, H., van Oosterom, A. T., ten Bokkel Huinink, W. W. & Pinedo, H. M. (1989). Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin. J Clin Oncol 7: 1099–1104.
Tinkler, S. D., Howard, G. C. & Kerr, G. R. (1992). Sexual morbidity following radiotherapy for germ cell tumours of the testis. Radiother Oncol 25: 207–212.
Tomic, R., Bergman, B., Damber, J. E., Littbrand, B. & Löfroth, P. O. (1983). Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, luteinizing hormone and prolactine. J Urol 130: 287–290.
van Basten, J. P., Jonker Pool, G., van Driel, M. F., Sleijfer, D. T., van der Wiel, H. B. & Hoekstra, H. J. (1995). The sexual sequelae of testicular cancer. Cancer Treat Rev 21: 479–495.
van Basten, J. P., Hoekstra, H. J., van Driel, M. F., Koops, H. S., Droste, J. H., Jonker Pool, G., van de Wiel, H. B. & Sleijfer, D. T. (1997a). Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy.. J Clin Oncol 15: 2442–2448.
van Basten, J. P., Jonker-Pool, G., van Driel, M. F., Sleijfer, D. T., Droste, J. H. J., van de Wiel, H. B. M., Koops, H. S., Molenaar, W. M. & Hoekstra, H. J. (1997b). Sexual functioning after multimodality treatment for disseminated nonseminomatous testicular germ cell tumor. J Urol 158: 1411–1416.
von Eschenbach, A. C. (1980). Sexual dysfunction following therapy for cancer of the prostate, testis and penis. Front Radiat Ther Oncol 101: 109–116.
Williams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A. & Loehrer, P. J. (1987). Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316: 1435–1440.
Author information
Authors and Affiliations
Additional information
This work represents part of the thesis of Ch. Albrecht at Hanover University Medical School.This paper was presented in part at the 9th European Cancer Conference on Clinical Oncology (ECCO 9), Hamburg, 14–18 September 1997
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hartmann, J., Albrecht, C., Schmoll, HJ. et al. Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer 80, 801–807 (1999). https://doi.org/10.1038/sj.bjc.6690424
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690424
Keywords
This article is cited by
-
Goal-Focused Emotion-Regulation Therapy (GET) for young adult survivors of testicular cancer: a pilot randomized controlled trial of a biobehavioral intervention protocol
Trials (2020)
-
Fertility as a priority among at-risk adolescent males newly diagnosed with cancer and their parents
Supportive Care in Cancer (2015)
-
Fertility preservation in men with cancer
Reproductive Medicine and Biology (2014)
-
Fertility Preservation in the Male with Cancer
Current Urology Reports (2013)